NIDDK


Also found in: Acronyms.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

an institute of the National Institutes of Health that conducts and supports basic and applied research and provides leadership for a national program in diabetes, endocrinology, and metabolic diseases; digestive diseases and nutrition; and kidney, urological, and hematologic diseases.

NIDDK

National Institute of Diabetes and Digestive and Kidney Diseases.
References in periodicals archive ?
The NIDDK conducts and supports research on many of the most serious diseases affecting public health.
The NIDDK supports research projects concerned with diabetes in Hispanics, including projects that address complications of the disorder in this population and projects that focus on primary prevention of diabetes.
Liu notes that the NIDDK team turned up no gender differences in the hypothalamus, the brain area responsible for basic physiological responses to hunger and satiation.
NIDDK has established a repository for the archiving of data sets, as well as genetics and tissues from NIDDK sponsored clinical trials and epidemiological studies (http://pubnts06.
In 2003, the rate for new cases of kidney failure was 338 per million population, down slightly from 2002 , NIDDK reported.
gov; James Hyde, Division of Diabetes, Endocrinology, and Metabolic Diseases, NIDDK, 6707 Democracy Blvd, Rm 609, MSC 5460, Bethesda, MD 20892-5460 USA, 301-594-7692, e-mail: jh486z@nih.
Rewriting NIDDK prose is a strange job to give to a person who is an expert on plagiarism," he says in an Oct.
Neither the NIDDK, CMS, nor any non-profit kidney association had any interest.
gov; James Hyde, Division of Diabetes, Endocrinology, and Metabolic Diseases, NIDDK, 6707 Democracy Bird, Rm 609, MSC 5460, Bethesda, MD 20892-5460 USA, 301-594-7692, e-mail: jh486z@nih.
NIH supported the study through a special fund for type 1 diabetes research established by Congress in 1997 and coordinated by NIDDK.
The NIDDK invites submission of innovative ideas and approaches toward accelerating progress and overcoming research barriers to the prevention, treatment and cure of type 1 diabetes and its complications.